Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
BMNDF
)
0.7000
UNCHANGED
Last Price
Updated: 9:30 AM EST, Jan 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.7000
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.7000
Today's Range
0.7000 - 0.7000
52wk Range
0.0887 - 0.7000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
November 20, 2024
Via
ACCESSWIRE
Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
July 18, 2024
Via
ACCESSWIRE
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
+120.40%
+120.40%
6 Month
+198.25%
+198.25%
1 Year
+597.91%
+597.91%
More News
Read More
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
September 14, 2023
From
Biomind Labs Inc.
Via
Business Wire
Cybin, GH Research Among Top Psychedelic Movers Of Today
January 27, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
January 26, 2023
Via
Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
January 25, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
Via
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via
Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via
Benzinga
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
November 15, 2022
Via
Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
Via
Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
Via
Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
November 04, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
Via
Benzinga
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
October 27, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
